Effect of neurotropin in postoperative analgesia in patients undergoing upper-abdominal surgeries

GAO Wei,LIU Xiao-yu,ZENG Qiu-ting,DUAN Man-lin,XU Jian-guo
2012-01-01
Abstract:Objective To observe whether neurotropin(analgecine) could reduce the consumption of sufentanil for postoperative analgesia in patients underwent upper-abdominal surgeries. Methods This was a randomized, single-blind and controlled trial. Thirty-eight patients scheduled for selective upper-abdominal operation were randomly divided into neurotropin group (group N,n=20) and sufentanil group (group S,n=18). Before the end of operation, patients in group N were given 7.2U of neurotropin, and then repeated once at 12 and 24 h with the same dose. Sufentanil was administered continuously with a intravenous pump (3 μg/kg sufentanil into 100 ml saline, delivering dose was 0.5 ml/h, the bolus was 2.0 ml, and lockout time was 15 min). Patients in group S were administered 3 μg of sufentanil at the moment before the end of operation and followed by the same sufentanil PCA. Following varibles were recorded: visual analogue score(VAS) of pain at rest and 90° turn over, Ramsay score, and adverse effects at 1, 4, 8, 12, 24, 36, 48 h after the operation.Results Compared with group S, patients in group N showed no significant difference in the Ramsay score and VAS of pain at rest and 90° turn over, but the total comsumption of sufentanil in group N decreased significantly (P<0.05). No adverse events were found and no remedy analgesics were given. Conclusion Administration of neurotropin combined with sufentanil have a preferable therapeutic effect for postoperative pain and reduce the amount of sufentanil consumption.
What problem does this paper attempt to address?